Galena Biopharma, a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, says it will be presenting at the 16th Annual BIO CEO & Investor Conference next week in New York City. The company's President and Chief Executive Officer, Mark J. Anh, Ph.D. will deliver a corporate update at the conference on Monday, February 10, 2014 at 9:00 am EST.
The conference is taking place at the Waldorf Astoria Hotel in New York City, New York. Those who wish to see the presentation are advised to visit the Investors section of Galena Biopharma's website: investors.galenabiopharma.com.
Recently, Galena Biopharma's share price rose from $5.00 on December 31, 2013 to over $7.00 in the past three weeks. That, say analysts, stems from the positive news that has been emerging concerning the biopharmaceutical company's oncology treatments.
More information about Galena Biopharma and its growth potential can be found at: galenabiopharma.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for "The Mission Report" at MissionIR.com
Please see disclaimer on the MissionIR website www.missionir.com/disclaimer.html
MissionIR provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.missionir.com